Inhibitors of P38 and methods of using the same
US7902192B2 · kind B2 · utility
1Cited by
28References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2004 |
| Grant date | Mar 8, 2011 |
| Priority date | — |
| Expiry date | Dec 12, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In general, the present invention relates to compounds capable of inhibiting p38, methods for inhibiting p38 in vivo or in vitro, and methods for treating conditions associated with p38 activity or cytokine activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.